KYAN Therapeutics is a clinical-stage AI company leveraging its proprietary technology platforms to transform the way patients are treated.
KYAN Therapeutics's investors include Altara Ventures, K3, Seeds Capital, Cedars-Sinai Accelerator.
KYAN Therapeutics is headquartered in Singapore, Singapore.
KYAN Therapeutics is a clinical-stage AI company leveraging its proprietary technology platforms to transform the way patients are treated.
KYAN Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"KYAN Therapeutics — Funding & Investors." VCBacked, May 1, 2024, https://www.vcbacked.co/company/kyan-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). KYAN Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/kyan-therapeutics
{{cite web |title=KYAN Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kyan-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated